The Australian market is following Wall Street?s lead to trade lower today, weighed down by heavy losses for the miners. Imugene is surging 5.5% today after the biotech company announced a new clinical trial supply agreement with Merck and Pfizer. Lovisa is rallying today on the back of a bullish broker note out of Macquarie which said Lovisa has strong growth opportunities in the Chinese and Indian markets. Snapchat is adding TikTok-like AR music lenses through a new deal with Sony Music Entertainment, allowing Snap users to access songs from Sony?s artists, in a bid to better compete with TikTok for user engagement.
VIDEO: Imugene soars 5.5% after signing a new trial supply agreement with Merck & Pfizer.
Video Player is loading.